Zenas BioPharma, Inc. (ZBIO)
(Delayed Data from NSDQ)
$30.19 USD
-1.61 (-5.06%)
Updated Oct 28, 2025 03:59 PM ET
After-Market: $30.30 +0.11 (0.36%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Zenas BioPharma, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ZBIO 30.19 -1.61(-5.06%)
Will ZBIO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for ZBIO based on the 1-3 month trading system that more than doubles the S&P 500.

Other News for ZBIO
ZBIO: Citigroup Raises Price Target, Maintains Buy Rating | ZBIO Stock News
ZBIO: Morgan Stanley Raises Price Target, Maintains Overweight Rating | ZBIO Stock News
ZBIO: HC Wainwright & Co. Raises Price Target, Maintains 'Buy' Rating | ZBIO Stock News
Crossed Above 20 Day Moving Average appears for ZBIO after 33.08% move
Zenas BioPharma price target raised to $34 from $31 at Morgan Stanley